Pharmaceutical Quality by Design: Principles and Applications discusses the Quality by Design (QbD) concept implemented by regulatory agencies to ensure the development of a consistent and high-quality pharmaceutical product that safely provides the maximum therapeutic benefit to patients. The book walks readers through the QbD framework by covering the fundamental principles of QbD, the current regulatory requirements, and the applications of QbD at various stages of pharmaceutical product development, including drug substance and excipient development, analytical development, formulation development, dissolution testing, manufacturing, stability studies, bioequivalence testing, risk and assessment, and clinical trials. Contributions from global leaders in QbD provide specific insight in its application in a diversity of pharmaceutical products, including nanopharmaceuticals, biopharmaceuticals, and vaccines. The inclusion of illustrations, practical examples, and case studies makes this book a useful reference guide to pharmaceutical scientists and researchers who are engaged in the formulation of various delivery systems and the analysis of pharmaceutical product development and drug manufacturing process. - Discusses vital QbD precepts and fundamental aspects of QbD implementation in the pharma, biopharma and biotechnology industries - Provides helpful illustrations, practical examples and research case studies to explain QbD concepts to readers - Includes contributions from global leaders and experts from academia, industry and regulatory agencies
Pharmaceutical Microbiology: Essentials for Quality Assurance and Quality Control presents that latest information on protecting pharmaceutical and healthcare products from spoilage by microorganisms, and protecting patients and consumers. With both sterile and non-sterile products, the effects can range from discoloration to the potential for fatality. The book provides an overview of the function of the pharmaceutical microbiologist and what they need to know, from regulatory filing and GMP, to laboratory design and management, and compendia tests and risk assessment tools and techniques. These key aspects are discussed through a series of dedicated chapters, with topics covering auditing, validation, data analysis, bioburden, toxins, microbial identification, culture media, and contamination control. - Contains the applications of pharmaceutical microbiology in sterile and non-sterile products - Presents the practical aspects of pharmaceutical microbiology testing - Provides contamination control risks and remediation strategies, along with rapid microbiological methods - Includes bioburden, endotoxin, and specific microbial risks - Highlights relevant case studies and risk assessment scenarios
Which performance measures should you use? The obvious answer is that it depends on what you want to achieve, which someone else should never define for you. After all, it is your organization, your department, or your process. But once you are clear about what you want to accomplish, how do you sort through a variety of possible metrics and decide which are best? Then, given the list of metrics you believe are useful or necessary, how do you define them in more detail to ensure that the right data are gathered at the appropriate frequency and that the resulting information gets to the right people so that they can make proper decisions? This book provides a clarifying perspective for those who know that metrics need to be developed but are unsure as to the steps to follow in developing and deploying them. It focuses on making sure that the metrics selected will guide people and processes in the direction the organization wants to go, and allow continual evaluation of success. Every highly effective organization is unique in some strategic way, and the metrics used should reflect these differences. Studying high performers can be useful from a learning standpoint, but simply adopting what someone else is doing is likely to take you off your track and put you on theirs. The concepts in this book will put you on the correct track and give you the tools to stay on it.
Biocontamination Control for Pharmaceuticals and Healthcare outlines a biocontamination strategy that tracks bio-burden control and reduction at each transition in classified areas of a facility. The first edition of the book covered many of the aspects of the strategy, but the new official guidance signals that a roadmap is required to fully comply with its requirements. Completely updated with the newest version of the EU-GPM (EN17141) the new edition expands the coverage of quality risk management and new complete examples to help professionals bridge the gap between regulation and implementation. Biocontamination Control for Pharmaceuticals and Healthcare offers professionals in pharma quality control and related areas guidance on building a complete biocontamination strategy. - Includes the most current regulations - Contains three new chapters, including Application of Quality Risk Management and its Application in Biocontamination Control, Designing an Environmental Monitoring Programme, and Synthesis: An Anatomy of a Contamination Control Strategy - Offers practical guidance on building a complete biocontamination strategy
Failure to adequately control any microbial challenge associated within process or product by robust sterilisation will result in a contaminated marketed product, with potential harm to the patient. Sterilisation is therefore of great importance to healthcare and the manufacturers of medical devices and pharmaceuticals. Sterility, sterilisation and sterility assurance for pharmaceuticals examines different means of rendering a product sterile by providing an overview of sterilisation methods including heat, radiation and filtration. The book outlines and discusses sterilisation technology and the biopharmaceutical manufacturing process, including aseptic filling, as well as aspects of the design of containers and packaging, as well as addressing the cleanroom environments in which products are prepared. Consisting of 18 chapters, the book comprehensively covers sterility, sterilisation and microorganisms; pyrogenicity and bacterial endotoxins; regulatory requirements and good manufacturing practices; and gamma radiation. Later chapters discuss e-beam; dry heat sterilisation; steam sterilisation; sterilisation by gas; vapour sterilisation; and sterile filtration, before final chapters analyse depyrogenation; cleanrooms; aseptic processing; media simulation; biological indicators; sterility testing; auditing; and new sterilisation techniques. - Covers the main sterilisation methods of physical removal, physical alteration and inactivation - Includes discussion of medical devices, aseptically filled products and terminally sterilised products - Describes bacterial, pyrogenic, and endotoxin risks to devices and products
Handbook of Analytical Quality by Design addresses the steps involved in analytical method development and validation in an effort to avoid quality crises in later stages. The AQbD approach significantly enhances method performance and robustness which are crucial during inter-laboratory studies and also affect the analytical lifecycle of the developed method. Sections cover sample preparation problems and the usefulness of the QbD concept involving Quality Risk Management (QRM), Design of Experiments (DoE) and Multivariate (MVT) Statistical Approaches to solve by optimizing the developed method, along with validation for different techniques like HPLC, UPLC, UFLC, LC-MS and electrophoresis. This will be an ideal resource for graduate students and professionals working in the pharmaceutical industry, analytical chemistry, regulatory agencies, and those in related academic fields. - Concise language for easy understanding of the novel and holistic concept - Covers key aspects of analytical development and validation - Provides a robust, flexible, operable range for an analytical method with greater excellence and regulatory compliance
A Handbook of Artificial Intelligence in Drug Delivery explores the use of Artificial Intelligence (AI) in drug delivery strategies. The book covers pharmaceutical AI and drug discovery challenges, Artificial Intelligence tools for drug research, AI enabled intelligent drug delivery systems and next generation novel therapeutics, broad utility of AI for designing novel micro/nanosystems for drug delivery, AI driven personalized medicine and Gene therapy, 3D Organ printing and tissue engineering, Advanced nanosystems based on AI principles (nanorobots, nanomachines), opportunities and challenges using artificial intelligence in ADME/Tox in drug development, commercialization and regulatory perspectives, ethics in AI, and more. This book will be useful to academic and industrial researchers interested in drug delivery, chemical biology, computational chemistry, medicinal chemistry and bioinformatics. The massive time and costs investments in drug research and development necessitate application of more innovative techniques and smart strategies. - Focuses on the use of Artificial Intelligence in drug delivery strategies and future impacts - Provides insights into how artificial intelligence can be effectively used for the development of advanced drug delivery systems - Written by experts in the field of advanced drug delivery systems and digital health
Preface for HVAC Site Acceptance Test for Pharmaceutical Plants Introduction The HVAC (Heating, Ventilation, and Air Conditioning) systems play a crucial role in pharmaceutical plants, ensuring that environmental conditions are tightly controlled to meet stringent regulatory requirements. The integrity of these systems directly impacts the quality and safety of pharmaceutical products. Therefore, a thorough and meticulously documented site acceptance test (SAT) is essential before commissioning any HVAC system in a pharmaceutical plant. Purpose The purpose of this document is to outline the procedures and criteria for conducting the HVAC site acceptance test (SAT) in pharmaceutical plants. The SAT ensures that the installed HVAC system operates according to the specified design, meets regulatory standards, and fulfills the requirements for maintaining controlled environments critical for pharmaceutical production. Scope This document covers the SAT procedures for HVAC systems, including testing methodologies, performance criteria, documentation requirements, and acceptance standards. It is intended for use by project managers, validation engineers, quality assurance personnel, and HVAC contractors involved in the commissioning and qualification of HVAC systems in pharmaceutical plants. Importance of HVAC Systems in Pharmaceutical Plants Environmental Control: HVAC systems maintain temperature, humidity, and air quality within specified ranges, essential for product stability and compliance with good manufacturing practices (GMP). Contamination Control: Properly functioning HVAC systems prevent cross-contamination and ensure a sterile environment, which is vital for the production of drugs and medical products. Regulatory Compliance: Compliance with regulatory standards, such as those set by the FDA, EMA, and other global health authorities, is mandatory for pharmaceutical plants. The SAT is a critical step in demonstrating that the HVAC system meets these stringent requirements. Product Quality: The consistent operation of HVAC systems is essential to ensure the quality and efficacy of pharmaceutical products. Any deviations can lead to compromised product integrity and potential recalls. Objectives The primary objectives of the HVAC SAT are: Verification of System Installation: Ensure that the HVAC system is installed according to design specifications and manufacturer guidelines. Operational Performance Testing: Validate that the HVAC system operates within specified parameters for temperature, humidity, airflow, and filtration. Compliance with Regulations: Confirm that the HVAC system meets all relevant regulatory standards and guidelines. Documentation and Reporting: Provide comprehensive documentation and reports to support the validation process and facilitate regulatory inspections. Structure of the Document This document is structured as follows: Preparation for SAT: Overview of pre-test preparations, including reviewing design specifications, regulatory requirements, and preparing test protocols. SAT Procedures: Detailed procedures for conducting the SAT, including test methods, instrumentation, and data collection. Performance Criteria: Specification of the performance criteria and acceptable limits for various parameters such as temperature, humidity, and airflow. Documentation Requirements: Guidelines for documenting the SAT process, including test results, deviations, and corrective actions. Acceptance and Approval: Criteria for acceptance and the process for approval by relevant stakeholders. Conclusion The HVAC site acceptance test is a critical component in the commissioning of pharmaceutical plants, ensuring that the environmental conditions necessary for product quality and regulatory compliance are met. This document provides a comprehensive framework for conducting the SAT, emphasizing the importance of meticulous testing and documentation to achieve a validated and reliable HVAC system.
In the previous few decades, the discipline of pharmaceutics has experienced substantial change. Today, more than ever, a thorough understanding of current pharmaceutics is required as the research pertaining to medication transport and formulation advances. For those studying, teaching, or working in the pharmaceutical sciences, this textbook, "Modern Pharmaceutics," is a vital tool. Gaining a comprehensive grasp of the concepts and applications of contemporary pharmaceutics is the aim of this course. This book offers a comprehensive yet fair review of the subject, covering everything from the fundamentals of drug delivery systems to the most recent developments in pharmaceutical technology. In order to help the reader navigate the complexity of pharmaceutics, the chapters in this book are carefully arranged. The book begins with the fundamental notions and moves on to more complex subjects, providing a thorough and progressive learning experience. Drug delivery methods, pharmaceutical formulations, cutting-edge technology, and ethical and regulatory issues are important areas of study. The emphasis in this work is on applying theoretical knowledge in real-world situations.
Whether striving to protect citizens from financial risks, climate change, inadequate health care, or the uncertainties of the emerging “sharing” economy, regulators must routinely make difficult judgment calls in an effort to meet the conflicting demands that society places on them. Operating within a political climate of competing demands, regulators need a lodestar to help them define and evaluate success. Achieving Regulatory Excellence provides that direction by offering new insights from law, public administration, political science, sociology, and policy sciences on what regulators need to do to improve their performance. Achieving Regulatory Excellence offers guidance from leading international experts about how regulators can set appropriate priorities and make sound, evidence-based decisions through processes that are transparent and participatory. With increasing demands for smarter but leaner government, the need for sound regulatory capacity—for regulatory excellence—has never been stronger.
